CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Clinigen Group PLC Company Snapshot
Clinigen Group PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clinigen Group PLC with three other miscellaneous service companies in Europe: AddLife AB of Sweden (2017 sales of 2.33 billion Swedish Kronor [US$268.05 million] of which 60% was LabTech), Genmab A/S of Denmark (2.37 billion Danish Kroner [US$374.99 million] of which 100% was Pharmaceticals), and BB Biotech AG which is based in Switzerland (270.33 million Swiss Francs [US$270.06 million] of which 100% was Investing & Related Activity).

Sales Analysis. During the year ended June of 2017, sales at Clinigen Group PLC were £302.30 million (US$407.96 million). This is a decrease of 11.1% versus 2016, when the company's sales were £339.90 million. Contributing to the drop in overall sales was the 40.4% decline in Managed Access, from £100.80 million to £60.10 million. There were also decreases in sales in Clinical Trial Services (down 20.3% to £109.90 million) . However, these declines were partially offset by the increase in sales of Link Healthcare (up 107.3% to £50.80 million) and Specialty Pharmaceuticals (up 11.6% to £41.40 million) and Global Access (up 1.3% to £40.10 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Clinigen Group PLC
  Stock Performance Chart for Clinigen Group PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 858.50p
(Figures in Pounds Sterling)
1 Week -1.5%   13 Weeks -5.7%  
4 Weeks -17.7%   52 Weeks 0.4%  
 
Clinigen Group PLC Key Data:
  Ticker: CLIN Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 302,300,000
(Year Ending Jan 2018).
Employees: 498
  Currency: Pounds Sterling Market Cap: 1,049,945,500
  Fiscal Yr Ends: June Shares Outstanding: 122,300,000
  Share Type: Ordinary Closely Held Shares: 11,896,280
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.